Investing.com - Rani Therapeutics Holdings (NASDAQ: RANI) reported first quarter EPS of $-0.35, $0.05 better than the analyst estimate of $-0.40. Revenue for the quarter came in at $0.00 versus the consensus estimate of $130K.
Rani Therapeutics Holdings's stock price closed at $5.95. It is down -1.65% in the last 3 months and down -55.99% in the last 12 months.
Rani Therapeutics Holdings saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Rani Therapeutics Holdings's stock price’s past reactions to earnings here.
According to InvestingPro, Rani Therapeutics Holdings's Financial Health score is "weak performance".
Check out Rani Therapeutics Holdings's recent earnings performance, and Rani Therapeutics Holdings's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar